Guangxi Wuzhou Zhongheng Group Co., Ltd (SHA:600252)

China flag China · Delayed Price · Currency is CNY
2.180
-0.020 (-0.91%)
Jun 9, 2026, 3:00 PM CST
Market Cap6.94B -14.8%
Revenue (ttm)1.58B -13.1%
Net Income-408.05M
EPS-0.13
Shares Out 3.18B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume28,938,377
Open2.200
Previous Close2.200
Day's Range2.160 - 2.210
52-Week Range2.160 - 3.230
Beta0.09
Analystsn/a
Price Targetn/a
Earnings DateAug 28, 2026

About SHA:600252

Guangxi Wuzhou Zhongheng Group Co., Ltd, together with its subsidiaries, researches, develops, manufactures, and sells pharmaceuticals in China. The company offers traditional Chinese medicine, including Xueshuantong injection, Zhonghua Dieda Wan for traumatic injuries, Fuyanjing capsules, JieShiTong tablets, snake gall and fritillaria liquid, Kunyuean granules, and compound clam oral liquid for cardiovascular and cerebrovascular, neurology, endocrinology, orthopedics, ophthalmology, gynecology, pediatrics, respiratory, urinary system, and othe... [Read more]

Sector Healthcare
Founded 1993
Employees 2,843
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600252
Full Company Profile

Financial Performance

In 2025, SHA:600252's revenue was 1.75 billion, a decrease of -16.92% compared to the previous year's 2.10 billion. Losses were -357.09 million, -5.28% less than in 2024.

Financial Statements